Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Researchers Recruiting Females For Preventative Care Research

Research Center: Paratus Clinical
Locations:
Paratus Clinical Kanwal Clinic
Suite A8, Kanwal Medical Complex, 654 Pacific Hwy, Kanwal, NSW, 2259
Paratus Clinical Blacktown Clinic
Level 2, Suite 201, 114-116 Main Street, Blacktown, NSW 2148
Lead Doctors: Dr James Vandeleur (Kanwal), Dr Mariam Chaalan (Blacktown)
Ethics Committee: This study has been reviewed and approved by Bellberry Human Research Ethics Committee

Background

Vaccines can help to provide immunity against one or several diseases. The study is looking to understand if a new vaccine is effective in preventing healthy women from getting cytomegalovirus. This study is also testing how your body handles the vaccine and if the vaccine is safe.

Cytomegalovirus (CMV) is a common virus. Many people do not know they have it, because they may have no symptoms. Cytomegalovirus is a concern for pregnant women as it can pass on the virus to the unborn baby. A woman who develops an active CMV infection during pregnancy can pass the virus to her baby, who might then experience signs and symptoms. There are medications to treat newborns, however there is a need for more preventative care to reduce the spread of the virus. However, CMV can have complications that are not treatable. CMV can cause long term health problems in babies which can include: vision problems, hearing problems, issues with the nervous system.

This research is looking to understand if a vaccine can reduce the amount of cases of cytomegalovirus in women and thus prevent the virus from being passed to newborns.

This study seeks females aged 16-35. Participants are required to attend 8 study visits at the research site over a 3 year period and will be reimbursed to help cover the cost of travel and expenses for participating in this study.

Why Participate?

  • You will be helping to develop preventative care methods for this virus.
  • You may be helping to prevent this virus from spreading to newborns.
  • You will be helping researchers better understand how to protect women and their children from cytomegalovirus
  • You will be reimbursed to help cover the cost of travel and expenses.
  • When attending the screening visit, you will be informed if you already have the virus
  • You will be helping to advance medical research.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Women aged 16-35 who are in good health
  • Have direct contact to young children (≤5 years of age) at home or occupationally
  • Able to attend 8 study visits at the research site over approximately 3 years

What Next?

  1. Click the link below to enter your contact details and answer some eligibility questions.
  2. The research centre will then contact you by phone to discuss the trial and answer your questions.
Click Here to Enter Your Contact Details and Be Contacted by Phone About the Trial

Is This Study Not For You?

Enter your details to be notified via email about new studies in your area

Is This Study Not For You?

Enter your details to be notified via email about new studies in your area

Gender(Required)